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It is inevitable for tumor cells to deal with various mechanical forces in order to move from
primary tometastatic sites. In particular, the circulating tumor cells that have detached from
the primary tumor and entered into the bloodstream need to survive in a completely new
microenvironment. They must withstand hemodynamic forces and overcome the effects
of ﬂuid shear before they can leave the vascular system (extravasate) to establish new
metastatic foci. One of the hypotheses of the tumor cell extravasation process is based
on the so called “adhesion cascade” that was formulated and observed in the context
of leukocytes circulating in the vascular system. During this process, the cell needs to
switch between various locomotion strategies, from ﬂoating with the blood stream, to
rolling on the endothelial wall, to tumor cell arrest and crawling, and ﬁnally tumor cell
transmigration through the endothelial layer. The goal of this project is to use compu-
tational mechanical modeling to investigate the fundamental biophysical parameters of
tumor cells in circulation. As a ﬁrst step to build a robust in silico model, we consider a
single cell exposed to the blood ﬂow. We examine parameters related to structure of the
actin network, cell nucleus and adhesion links between the tumor and endothelial cells
that allow for successful transition between different transport modes of the adhesion
cascade.
Keywords: circulating tumor cells, metastatic cascade, cell deformation, computational modeling, immersed
boundary method
INTRODUCTION
The metastatic cascade is a multistep process in which cancer cells
from the primary side (of the solid tumor) are relocated to the
distant organs in which they grow to form new colonies. This pro-
cess, called a metastatic cascade, consists of several steps during
which cancer cells must ﬁrst invade the stroma surrounding the
primary tumor, intravasate, i.e., enter into the blood or lymphatic
system, survive in the circulation, extravasate into the secondary
site, invade the local matrix, and grow in the target organ (Cham-
bers et al., 2002; Nguyen et al., 2009; Psaila and Lyden, 2009;
Mina and Sledge, 2011).
The tumor cells in circulation (called the circulating tumor
cells, CTCs) are exposed to various microenvironmental factors
that are novel for the cells arising from the solid tumor mass. In
order to survive, the cells must withstand hemodynamic forces
and overcome the effects of ﬂuid shear (Wirtz et al., 2011). In
order to metastasize, the cells must leave the circulation system,
and one of the extravasation hypotheses is the so called “adhesion
cascade” that was formulated and observed in the context of cir-
culating leukocytes (reviewed in Nourshargh et al., 2010). During
this process, the tumor cell needs to switch between various loco-
motion strategies, from ﬂoating with the blood stream, to rolling
on the endothelial wall (EW), to tumor cell arrest and crawling,
and ﬁnally tumor cell transmigration through the endothelial layer
(Nourshargh et al., 2010; Wirtz et al., 2011).
The recent advent of technical devices capturing the CTCs from
patient’s peripheral blood (Hsieh et al., 2006;Alunni-Fabbroni and
Sandri, 2010; Farace et al., 2011; Kirby et al., 2012), allows the can-
cer biology community to gain enormous knowledge about the
biology of CTCs and their correlations with clinical outcomes
(Hou et al., 2010; Oakman et al., 2010; Swaby and Cristofanillli,
2011; Wendel et al., 2012). However, many aspects of CTC trans-
port and extravasation processes are still unknown. In particular,
the biophysical properties of CTCs that enable the completion
of the adhesive cascade have not been investigated in detail, and
many questions are still unanswered. How big are the CTCs? How
deformable are they? Are the CTC’s biophysical properties simi-
lar or distinct from the properties of the primary tumor cells and
other cells in the circulation? Do these physical properties change
over time? This provides a challenge from both biomechanical and
therapeutical perspectives.
The goal of this project is to use mathematical modeling to
investigate how cell deformability affects its translocation within
the vascular duct under the blood ﬂow, and how the physical prop-
erties of the cells change (globally or locally) when the cells switch
their locomotion strategies. This will allow us to identify combi-
nations of parameters that can be manipulated experimentally in
order to disrupt some steps of the adhesive cascade.
MATERIALS AND METHODS
Weuse the IBCell mathematical framework (the ImmersedBound-
ary model of a Cell; Rejniak, 2007a) to model a two-dimensional
(2D) deformable tumor cell traveling through a microvessel. The
cell is exposed to both hemodynamic forces exerted by the blood
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plasma ﬂow, and adhesive–repulsive forces between the tumor
cell attaching to or migrating along the EW of the microvessel
(Figure 1).
CTC STRUCTURE
The CTC structure is simpliﬁed to include two key elements deﬁn-
ing cell shape and stiffness: the cell actin cortex and cell nuclear
envelope. Both of these intracellular structures are modeled as
dense networks of linear Hookean springs indicated by blue links
C and gray links N in Figure 1, and mathematically deﬁned by
Eq. 5. The spring stiffness can be modiﬁed either globally (i.e.,
for each spring forming the nuclear envelope) or locally (i.e., for
an individual actin ﬁlament in the cortex). This allows us to test
their relative role in preserving the overall cell shape under the
blood ﬂow as well as in cell attachment and migration capabilities.
The whole cell is interpenetrated by the viscous incompressible
cytoplasm, but other intracellular elements (such as organelles,
microtubules, intermediate ﬁlaments) are omitted for simplicity
and to reduce computational costs. However, they can be incor-
porated in this model in a form of additional collections and/or
networks of springs.
EW STRUCTURE
Similarly, the EW is modeled as a mesh of short and relatively stiff
linear springs (shownas red links E inFigure 1 andEq. 5) that form
FIGURE 1 | Model schematics and equations. A schematic
representation of the 2D model of the tumor cell in circulation. The blood
vessel (red walls, E) is interpenetrated by a laminar ﬂow (gray arrows
representing blood velocity ﬁeld) that interacts with a circulating tumor cell
(CTC). The cell nucleus (gray, N) is surrounded by the cell cortex (blue, C)
that both deﬁne cell shape and stiffness. The cell near the endothelial wall
(EW) develops CTC–EW adhesive connections (green links, A). Insets show
the magniﬁcation of a meshwork deﬁning the nucleus and the cortex (top),
and the network deﬁning the EW and CTC–EW adhesive springs (bottom).
Representative springs of the cortex, nucleus, endothelium, and adhesive
CTC–EW links (XC–XC*, XN–XN*, XA–XA*, XE–XE*) are indicated by thick
lines. Equations 1–5 deﬁne the mathematical frameworks of the Immersed
Boundary method.
a uniform rigid wall. For simplicity, no individual endothelial cells
are included in the model, but in principle, they can be modeled
in a similar fashion as CTCs.
CTC–EW INTERACTIONS
The CTCs interact with EWs upon contact via the membrane
receptors located on both the tumor cell and the endothelium.
The proximity between CTC and EW results in the emergence of
adhesive links that are modeled as short linear Hookean springs
(indicated by green links A in Figure 1 and Eq. 5). These adhe-
sive links can be dynamically assembled and disassembled based
on the distance between CTC’s and EW’s receptors, as well as
adhesive spring stiffness. Since the main goal is to investigate cell
deformability, we assume that receptor–ligand binding is always
effective when the CTC–EW distance is small.
BLOOD PLASMA FLOW
We do not include the red blood cells or any other non-tumor
cells and take into account only the ﬂuid phase of the blood, i.e.,
the plasma. We model the blood plasma as a viscous incompress-
ible Newtonian ﬂuid governed by the Navier–Stokes equations
(Figure 1, Eqs 1 and 2). We assume that the velocity of the plasma
inside the microvessel has a parabolic proﬁle with zero velocity
at the microvessel walls. Thus, in the presence of no other obsta-
cles inside the microvessel, the ﬂuid ﬂow is laminar. However,
in the presence of the deformable tumor cells inside the duct, as
well as adhesive interactions between the ﬂowing cells and the
endothelium, the plasma ﬂow proﬁle may be distorted. For sim-
plicity, we neglect any changes that the plasma ﬂow may have on
the endothelium. However, we are aware that the blood ﬂow can,
for example, alter the expression of certain membrane receptors
in the endothelial cells that in turn may modify the CTC–EW
interactions.
IMMERSED BOUNDARY METHOD
Interactions between the CTCs, EWs, and the plasma ﬂow are
solved using the classical ﬂuid–structure interaction approach,
i.e., the immersed boundary method (Peskin, 2002 and Eqs 1–5
in Figure 1). In this system, Eq. 1 is the Navier–Stokes equa-
tion of a viscous incompressible ﬂuid deﬁned on the Cartesian
grid x = (x1,x2), where p is the ﬂuid pressure, μ is the ﬂuid
viscosity, ρ is the ﬂuid density, u is the ﬂuid velocity, and f is
the external force density. Equation 2 is the law of mass bal-
ance. Interactions between the ﬂuid and the material points X(l,t)
on the tumor cell and the EW boundaries (l is an index along
either the boundaries of the tumor cells Γt or the boundaries of
the EWs Γe), are deﬁned in Eqs 3 and 4. Here, the force den-
sity F(l,t) acting on the cell and wall boundaries is applied to
the ﬂuid using the 2D Dirac delta function δ, while all mate-
rial boundary points X(l,t) are carried along with the ﬂuid. The
boundary forces F(l,t) arise from elastic properties of the tumor
cell membranes, from rigid properties of the EWs and from CTC–
EW adhesion, and are all represented by the short linear Hookean
springs in Eq. 5, where S is the spring stiffness, L is the spring
resting length, and X*(l,t) is the adjacent, opposite, or neighbor-
ing point for the elastic, rigid, or adhesive forces, respectively
(the pairs of connected boundary points in the endothelium,
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the EW–CTC adhesion, the CTC nucleus, and cortex are indi-
cated in Figure 1 by wide red, green, gray, or blue segments,
respectively). These equations are solved using the ﬁnite difference
methods with a discrete approximation of the Dirac delta function
and are described in detail in Rejniak (2007a) and Rejniak and
Dillon (2007).
RESULTS
Individual tumor cells in circulation are exposed to the hemody-
namic forces and ﬂuid shear that the cells need to withstand in
order to keep their physical integrity. The goal of this investiga-
tion is to determine the biomechanical properties of the CTCs
(either persistent or dynamically changing during the course of
CTC voyage through the vascular system) that allow the cells to
survive in the blood stream and attach to the EW. First, we exam-
ine how the relative stiffness of the CTC cortex versus the stiffness
of the CTC nuclear envelope controls CTC deformation under
the blood ﬂow (see CTC Survival in the Blood Flow). Next, we
test how CTC cytoskeletal properties need to be modiﬁed in order
to attach and roll on the EW (see CTC Rolling on the Endothe-
lium). Finally, we examine how CTC cytoskeleton reorganization
and cell membrane receptor redistribution enable CTC anchor-
age and migration on the endothelium (see CTC Anchorage to
the EW). Since, we are concerned here with the fundamental bio-
physical parameters of a single deformable tumor cell only, the
current model does not include other kinds of cells (such as red
blood cells, leukocytes, platelets) that the CTC can collide with, or
the formation and dynamics of multicellular emboli. These could
be easily added to the model and will be considered in further
research.
CTC SURVIVAL IN THE BLOOD FLOW
We consider a single tumor cell under the blood plasma ﬂow in a
small 30-micron-wide and 75-micron-long vessel. The ﬂuid ﬂow
is assumed to have a parabolic proﬁle with a maximal velocity
of 0.6 mm/s in the center of the microvessel and 0 on the vessel
walls. Initially, the cell is circular with a diameter of 10 microns,
a 4-micron-wide nucleus, and a 2-micron-wide cortex band. We
independently simulated two cases that varied only by initial cell
location within the vessel, i.e., whether the cell was placed near
the EW or at the middle of the microvessel. The latter cell was
exposed to symmetrical hemodynamic forces, whereas the for-
mer cell was exposed to non-uniform blood shear stress with
increasing blood velocity afar from the EW. We used computer
simulations to trace how each cell is carried with the blood
ﬂow through the straight segment of the microvessel. Only two
model parameters were varied: the stiffness constant of individ-
ual ﬁbers forming the cell cortex and the stiffness constant of
the cell nuclear envelope. The baseline value in each case was
assumed to be 50 dyn/cm and was varied separately over the
sixfold range. The ﬁnal cell shapes after reaching 2/3 of the ves-
sel length was recorded for comparison and overexposed on the
same picture. A table showing ﬁnal cell conﬁgurations for the
whole range of stiffness constants is shown in Figure 2. Except
for the case of a very stiff cortex (column 6 in Figure 2), when all
cells retain their initial circular shapes, the cells located near the
EW underwent signiﬁcant deformations due to the non-uniform
blood ﬂow shear stress. However, when the stiffness of the cell
cortex is ﬁxed, the increasing stiffness of the cell nuclear enve-
lope results in diminished deformation of the whole cell. This
is the most visible in Figure 2, column 4, where the difference
in the shape of the near-wall cell in the bottom row versus the
top row changes from elliptical to circular. A very ﬂexible cortex
results in cell elongation that in extreme cases (Figure 2, col-
umn 1) may resemble cytoplasmic fragmentation (clasmatosis).
Thus, actin cortex stiffness is crucial for cell survival during its
passive transport by the blood ﬂow, and a combination of soft
cortex and soft nuclear envelope may lead to cell damage by the
blood stream.
CTC ROLLING ON THE ENDOTHELIUM
Based on simulations from the previous section (Figure 2), we
consider only these combinations of parameters for which the
CTCs were able to survive under the blood ﬂow, i.e., the stiffness
values for both the cortex and the nucleus from the top-right quar-
ter in Figure 2. The goal was to investigate which of these CTCs
were able to attach to and roll on the endothelium wall. Four time
snapshots from each simulation are shown in Figures 3A–D.
Only in the case of a very stiff cortex (sixfold of the baseline,
Figures 3B,D) the cell was able to roll over the endothelium wall
(a ﬁxed part of the cell cortex is stained to show its transloca-
tion along the cell perimeter). However, there is a difference in the
speed of cell rolling, and a less stiff nucleus contributes to faster cell
movement (Figure 3B). When both the cell cortex and the nucleus
are softer, the cell deforms and is carried with the blood plasma
ﬂow (Figure 3A). In case of a stiff nucleus and a softer cortex, the
cell was initially deformed and attached to the endothelium, but
ﬁnally, its adhesive connections were broken, and the cell moved
apart from the endothelium (Figure 3C). These simulations indi-
cate that the transition in the CTC transport phase from ﬂoating
with the blood ﬂow to attaching and rolling on the EW requires
stiffening of the whole CTC cortex. The uniformly ﬂexible cell
cytoskeleton prevents the tumor cell from its stable anchoring to
the endothelium. In contrast, since the ﬂexible cell becomes more
easily elongated due to the blood shear stress, it is more likely that
it will be shredded out of the surface in contact and returned to
the blood stream. Increased CTC–EW adhesions have been tested
but did not improve cell adhesion and rolling abilities (results not
shown).
CTC ANCHORAGE TO THE EW
Simulations from the previous section (Figure 3C) showed that
the cell with a relatively stiff nucleus and softer cortex was able
to attach to the endothelium and migrate a short distance until
it was detached by the ﬂow. We tested the case in which the
CTC–EW attachment resulted in further softening of the cell cor-
tex around cell focal adhesions, but was unchanged elsewhere.
Four snapshots taken over a 10t period (2.5 times longer than
shown in Figure 3C) were overexposed on the same picture in
Figures 4A,B. Dynamical changes in the cell cortex allow the cell
to migrate successfully on the endothelium when simultaneously
exposed to the blood plasma ﬂow. Here, the cortex ﬁbers were
softened around the cell focal adhesions with the EW, and they
became stiffer immediately after the focal adhesions were broken.
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FIGURE 2 | Circulating tumor cell stiffness relationship. Circulating tumor
cell deformation under steady blood ﬂow in relation to the cell cortex versus
cell nuclear envelope stiffness. Final conﬁgurations of two separately
simulated cells that vary only by their location within the vessel (red) are
overexposed on one picture. The cell cortex stiffness (blue) and cell nuclear
envelope stiffness (gray) were varied by sixfold each.
FIGURE 3 | Circulating tumor cell rolling on the endothelium. Each
of the four cases (A–D) is characterized by a different cortex C and nucleus
N stiffness value, however the strength of all adhesive bonds is ﬁxed.
The values are reported similarly as in Figure 2. (A) both the cortex and
nucleus stiffness are 3-fold higher than the baseline; (B) the nucleus
stiffness is 3-fold and cortex stiffness is 6-fold higher than the baseline;
(C) nucleus 6-fold and cortex 3-fold; (D) both the nucleus and cortex
stiffness is 6-fold higher than the baseline. For each case, four time
snapshots (taken at time t, 2t, 3t, and 4t) are overexposed on the same
picture for comparison of cell deformation and translocation in each case.
A ﬁxed small part of the cell cortex is stained for illustration of the rolling
effect.
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FIGURE 4 | Circulating tumor cell migrating on the endothelium. Four
time snapshots (taken at time t, 2t, 5t, and 10t) are overexposed on the
same picture for comparison of cell deformation and translocation. (A)The
cell cortex is stained differently depending on its local stiffness: soft (cyan)
close to cell focal adhesion with EW, and stiff (blue) far from EW contacts.
(B) A ﬁxed small part of the cell cortex is stained for illustration of the
rolling effect.
All other cortex ﬁbers remained stiff. The softer and stiffer parts
of the cell cortex are stained differently in Figure 4A. The corre-
sponding images in Figure 4B show translocation of a small ﬁxed
part of the cell cortex around the cell circumference. These simu-
lations showed that transition from cell rolling, which requires a
quite stiff cytoskeleton, to cell anchoring and crawling, in which
the contact area between the CTCs and the EWs needs to increase
gradually, demands alterations in the cell cortex stiffness. This local
softening of the cell cytoskeleton along the contact area with the
EW may be potentially modulated by signals from the endothelial
cells in contact.
DYNAMICAL CHANGES IN THE CTC CYTOSKELETON DURING
ITS INTRAVENOUS TRANSPORT
Simulations of the IBCell model revealed that in order for the
CTC to progress from ﬂoating to rolling, to anchoring, and ﬁnally
to crawling, the stiffness of its cytoskeleton needs to be modi-
ﬁed differently in different cell compartments in a very dynamical
way (Figure 5). Cell rolling requires quite a stiff actin cortex that
can be pushed by the blood ﬂow without extensive deformation. It
also demands dynamical assembly–disassembly of CTC–EWadhe-
sion bonds between the cell front and its back. Upon transition
to anchoring, the CTC cytoskeleton must become more ﬂexible
along the contact surface. Too weak a cytoskeleton leads to cell
elongation and its drift with the blood ﬂow; too stiff a cytoskeleton
will result in persistent cell rolling. Cell crawling requires weaker
adhesive bonds and simultaneous changes in the CTC cytoskeletal
stiffness: softening in the cell compartment in contact with the
EWs, and stiffening in the cell compartment opposite to the con-
tact surface. These complementary and dynamic changes in the
CTC cytoskeletal properties enable the cell to complete the whole
adhesive cascade.
FIGURE 5 | Dynamical changes in the cell cytoskeleton during CTC
intravenous transport. Each of the steps of the adhesive cascade requires
different cytoskeletal properties of the CTC actin cortex stiffness (blue),
cortex stiffness near the adhesion sites (cyan), stiffness of the CTC nuclear
envelope (gray), and strength of the CTC–EW adhesion bonds (green). A
typical cell conﬁguration for each of the steps of the adhesive cascade is
shown in the top row together with a color-coded cell stiffness signature.
Lines represent the best continuous ﬁt of the computational data.
DISCUSSION
Recent experimental studies (Fuhrmann et al., 2011; Swaminathan
et al., 2011; Ketene et al., 2012) showed that normal, dysplastic,
and metastatic cells (derived either from patient tumors or from
cancer cell lines) exhibit a different degree of mechanical stiff-
ness and cell deformability. The overarching conclusion is that
even in the earliest stages of cancer development, the mechanical
properties of the cells are altered. As cancer cells get progres-
sively more invasive and metastatic, they display softer mechanical
characteristics that result in larger cell deformations and more
pronounced shape changes. There is also evidence of changes
in the structural components of the nuclear envelope in vari-
ous kinds of cancer cells (reviewed in Chow et al., 2012) that
may result in altered mechanical properties of the cells. Numer-
ous in vivo studies (Yamauchi et al., 2005; Stoletov et al., 2007,
2010) showed that metastatic tumor cells are quite deformable,
and both the cell cytoplasm and cell nucleus can undergo strong
compression and shape deformation in small capillaries. In par-
ticular, the length of cell nucleus can increase 1.6-fold, and the
cell major axis 3.9-fold in comparison to the same cell kind in
larger microvessels (Yamauchi et al., 2005). Moreover, the cells
arrested at the capillary bifurcation points can stretch and extend
their bodies in both directions (Figure 3, Yamauchi et al., 2005;
Figure 2, Stoletov et al., 2010). A change in nuclear morphology is
used as a criterion in the current pathological assessment of tumor
grade and progression. Nuclear deformations are also observed
during tumor cell migration, especially in conﬁned microenvi-
ronments, which have been linked to altered rigidity of the cell
nuclear envelope and changes in its ﬁber (laminins, actins, spec-
trins, titins) composition (Rowat et al., 2008; Friedl et al., 2011;
Chow et al., 2012).
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However, the precise mechanisms and extent of such defor-
mations in the CTCs in the blood ﬂow are not known. Despite
the continuously increasing library of biomechanical assays and
sophisticated bioengineering techniques for assessing various
properties of cancer cells and their cytoskeleton (reviewed in
Suresh, 2007), such precise measurements are difﬁcult to carry
in the ﬂuid microenvironment. Most of the currently used meth-
ods for capturing CTCs require cell attachment or anchorage to
the substrate. This may result in changes in the cytoskeletal prop-
erties of the cell in a way that subsequent measurements will
not reﬂect cell properties in circulation. We propose here to use
computational simulations to determine cell shape deformations
that may be compared to morphologies of CTCs from in vivo or
in vitro studies. This will provide a qualitative not quantitative
comparison; nevertheless it may point to possible alterations in
cell cytoskeleton stiffness.
The computational IBCell framework employed in this paper,
has been previously established as amodel of a deformable eukary-
otic cell (Rejniak, 2007a), and it was used to investigate the
formation of abnormal invaginations of the trophoblast tissue in
the human placenta (Rejniak et al., 2004), the development of
normal and aberrant morphologies of mammary epithelial acini
(Rejniak and Anderson, 2008a,b; Rejniak et al., 2010), as well as
various emerging patterns of invasive tumor colonies (Rejniak,
2005; Anderson et al., 2009). Here, we used it to model various
forms of transport of an individual CTC through the microves-
sel and CTC–EW interactions. We considered a single cell with a
deformable cortex and nucleus and tested parameters related to
the actin network and cell nuclear envelope stiffness that allow
for successful completion of the adhesion cascade steps. We did
not address the kinetics of the receptor–ligand pair, since this
mechanism has been extensively simulated by others, but mostly
under the assumption that the cells were non-deformable solid
spheres. Our goal was to investigate the complementary case. We
assumed that cell-endothelium adhesion is effective, but that the
cells are deformable. Thus, this model differs signiﬁcantly from
previously published models of cells in circulation. The individual
deformable but nucleus-free red blood cells were modeled in
(Pozrikidis, 2003, 2005) showing results similar to the soft nucleus
cases consider in this paper. The large colonies of interacting red
blood cells and platelets under the blood ﬂow were modeled in
(Zhang et al., 2009; Crowl and Fogelson, 2011; Zhao et al., 2012),
where platelet’s passive translocation within the cellular suspen-
sion of red blood cells was investigated. Adhesion and rolling of
leukocytes on EWs was modeled in (King and Hammer, 2001;
Migliorini et al., 2002; Eniola et al., 2003; Sun et al., 2003; Jad-
hav et al., 2005; Bose et al., 2010), where various mechanisms of
receptor–ligand bond formation and hydrodynamic interactions
between individual cells under the blood ﬂow were investigated.
However, these models have not addressed all the various modes
of intercapillary cell translocation using one comprehensive mod-
eling framework, as has been presented in this paper. Our work
shows that the CTC cytoskeleton needs to be dynamically modi-
ﬁed in a controlled way to enable the cell to pass through different
modes of translocation (i.e., from ﬂoating to rolling, to anchor-
ing, to crawling). In particular, the physical properties of the ﬁbers
forming the cell actin cortex need to be altered in response to
both blood shear stress and adhesive contacts with the endothe-
lium. In the case of cell rolling, we found out that the soft cells
were not able to roll in contrast to the stiff cells (such as solid
spheres). However, the cell cortex needed to be softened in order
for the cell to anchor and crawl on the EW, a case that has not been
modeled previously in this context. Such dynamical alterations
in cell mechanical properties might be modulated by intercellular
signaling and might be a subject of further experimental studies.
The model described in this paper is 2D, however, this com-
putational framework can be easily extended to 3D (Peskin, 2002;
Grifﬁth et al., 2007; Rejniak, 2007b). In the 3D version, the cell cor-
tex and nucleus can be discretized using a dense set of boundary
points connected with short linear springs in the form of cross-
linked ﬁbers (Figure 6). Similar discretization can be used for
the boundary of the vessel that together with stiff connecting
springs will form a rigid wall (Figure 6). The CTC–EW adhe-
sion links can be modeled using short springs like in the 2D case.
The immersed boundary equations in both cases have a similar
form (Figures 1 and 6). One advantage of the 3D model is the
FIGURE 6 |Three-dimensional model schematics and equations. A
schematic representation of the structure of the 3D cell (left, top), the
microvessel with a single attached cell (left, bottom), and model equations in
three dimensions (right).
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possibility of investigating blood vessels of different curvatures
and sizes. A disadvantage is in the required computational power.
The 3Dmodel needs to be runwith a very small time step to ensure
the ﬂuid dynamics code stability and convergence, and thus it will
take much longer to complete full 3D computations. However,
we do not expect that the 2D and 3D models will differ in their
qualitative predictions.
Other extensions of the current model can include a compari-
son of cell deformations under blood ﬂow of different velocities,
and in vessels of different size, including small capillaries. We will
also test cells of different nucleus-to-cytoplasm ratios, since it has
been shown that CTC can vary signiﬁcantly among each other
(Marrinucci et al., 2010). Recent studies indicate that CTCs can
form aggregates in the blood system that may also contain other
circulating cells, such as leukocytes, macrophages, and platelets
(Cho et al., 2012). We will investigate the dynamics of such emboli
in the circulation, and whether the presence of other cells can
increase the chance of CTC attachment to the EWs. Further exper-
imental studies, out of the scope of our computational group,
will be required to determine whether the cell physical properties
observed using this computational approach can be manipulated
experimentally to disrupt some steps of the adhesive cascade,
and may be potentially used to develop the next generation of
therapeutic interventions.
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